Giving Patients The ‘Right To Try’ Experimental Drugs Is A Political Maneuver, Not A Lifesaver


Published:

After a year in which President Donald Trump devoted much of his health policy attention to the repeal and replace of the Affordable Care Act, Trump used part of his recent State of the Union address to press Congress to focus attention in 2018 on a new health priority – the passage of “right to try” legislation.

Right to try legislation gives terminally ill patients the right to use experimental medications that have not yet been approved by the Food and Drug Administration. In 2017, the US Senate unanimously passed HR 878, legislation that would do just that. The president’s address has pressured the US House to follow suit, where a bill is being voted on this March 13.

President Trump’s push for the passage of right to try nationally builds on the efforts of the Libertarian-leaning Goldwater Institute, which has used the broad popularity of the policy to help achieve passage of similar legislation in 38 states, even though it diverges with current federal regulations.

Despite these state gains and the policy’s growing popularity among states, ethical questions remain about the tangible impact of a federal right to try law on Americans with terminal illnesses. Most notably, a growing body of evidence from policy analysts argues that the legislation would unfortunately accomplish very little change for most patients, and it could actually make it harder to get new drugs approved in the future.

How The Drug Approval Process Works

Pharmaceuticals in the United States are regulated by the FDA. When a drug company develops a new compound intended for patient use, the medication goes through three phases of clinical trials that often take years to complete.

The first phase of trials requires a company to prove the drug is relatively safe for humans – that the drug itself will not poison the patient. These phase 1 trials are often conducted on as few as 30 patients.

In later phases, the clinical trials test whether the drug is effective at treating the condition for which it is intended without problematic side effects. It is at this stage that the vast majority of drugs fail to pass approval, because many drugs turn out to be ineffective or to cause severe side effects.

The right to try legislation the Trump administration is currently pushing would authorize doctors to administer drugs that have cleared the first phase, but which have not yet completed these later human clinical trials. By doing so, the legislation gives terminally ill patients the right to use potentially lifesaving medications without rigorous testing from the FDA and without years of waiting for the drugs to become commercially available.

For people suffering from terminal conditions such as amyotrophic lateral sclerosis, or ALS, for which there are promising treatments in the midst of the approval process, the legislation brings hope.

That said, we believe the promises made by right to try advocates are far greater than the actual impact it will have on patients.

‘Right To Try’ Grants No Real Rights

Despite good intentions – and the legislation’s name – right to try legislation grants no rights. It would merely grant permission for a patient to try to get experimental medication from a pharmaceutical company.

Patients would be allowed to try experimental drugs, but nothing in the legislation would make it mandatory for pharmaceutical companies to provide these medications.

The reasons for a company to withhold a drug are many. Giving access to preapproval drugs can be costly, particularly given the limited supply, and almost no medical insurance will cover experimental treatments. Access to the drugs will likely only be feasible for wealthy Americans who can afford to pay for the treatment, as well as the consequences of any negative side effects out of pocket.

Many drug companies also worry that making the drug available without approval opens them up to lawsuits if the drugs prove ineffective or have unforeseen side effects. The current federal right to try proposal does provide some protections for companies in this regard, but until those protections have been tested in court, it is likely companies will remain cautious.

Providing the drug to patients outside of clinical trials can also be disruptive to the approval process because it can lead to data on negative clinical outcomes outside the highly controlled trial setting. While new legislation prevents this data from being used unless it is deemed “critical to determining safety,” bad outcomes might give the FDA pause and delay the approval of drugs that might otherwise be available sooner.

The ‘Right To Try’ Legislation Changes Very Little

Beyond these issues, federal right to try legislation will have minimal impact on the availability of experimental drugs for patients. Not only have 38 states already passed similar legislation, but the FDA already has a program in place designed to provide patients with experimental medications.

This program, known as the “compassionate use” program, performs essentially the same function as the right to try legislation, allowing patients to try experimental drugs after approval from a review board and panel of experts. In recent years, the FDA has approved 5,816 of 5,849 requests – a 99.4 percent approval rate.

While right to try would eliminate the FDA’s role in this process, the legislation does little more than slightly simplify a process that already exists to ensure that those who need experimental medications have access to them.

More Harm Than Good?

Ultimately, we believe right to try is poised to give the Trump administration a political win on a popular public policy but will do little to change the status quo for terminally ill patients. Some opponents say, if anything, it could give terminally ill patients false hope for new access to drugs they already can obtain through existing FDA policy.

Even if right to try does simplify federal regulation, patients must still convince a reticent pharmaceutical industry to provide drugs outside of trials, and patients must still bear the costs for these experimental treatments, which is out of reach for almost all Americans.

The right to try legislation will score the president and members on both sides of the aisle in Congress points, but ultimately it will change little for terminally ill patients and their families.

Morten Wendelbo is a development researcher specializing in complex emergency preparedness and response. He has experience working with inter-governmental institutions, as well as country and local governments to implement comprehensive response strategies to natural disasters.

Dr. Timothy Callaghan studies health policy and management, with expertise in health policy and politics, Medicaid, Medicaid expansion, health insurance and the Affordable Care Act.

This article was republished from The Conversation.

See also:
Slow Medicine: A Conversation With J. Ladd Bauer MD
CVS Merger With Aetna: Health Care Cure Or Curse?

The Conversation

Edit Module
Edit ModuleShow Tags
Edit Module Edit ModuleShow Tags

Daily Astrology

April 3, 2020

The Leo Moon and Aries Sun make a heart warming and confidence building trine during the mid-afternoon. The uplifting alignment builds self-esteem in a happy, sun-splashed way. This is a favorable period for showing passion and initiative. Venus also…
Edit ModuleShow Tags

Alternative Health Directory

Browse all listings »

Edit ModuleShow Tags
Edit ModuleShow Tags

Calendar

March 2020

In this time of social distancing, it's important to make time and create new habits around maintaining your wellness. In support of that, we have gathered over 30 professionals who have...

Cost: Free

Where:
Online
, NH


Sponsor: Ramsay Media LLC
Contact Name: Paul Ramsay
Website »

More information

"When diet is wrong, medicine is of no use. When diet is correct, medicine is of no need" A whopping 70 million people in the US suffer from some digestive issue, from constipation to...

Cost: $40 till 3/25 ($45 after)

Where:
Online
, MA


Sponsor: www.SOHUM.org
Telephone: 508-329-3338
Contact Name: Ritu Kapur
Website »

More information

Show More...
Show Less...

Reconceptualizing Mental Health Treatment through Radical Compassion: A Personal Narrative of an Asian American Woman with Pata Suyemoto, PhD **PLEASE NOTE - This lecture will only be held...

Cost: Free

Where:
Online
, MA


Sponsor: Center for Mindfulness and Compassion
Website »

More information

Join us for Monday Morning Meditation and discover the serenity and silence within your own being. This group is designed for people who are new to meditation and looking to explore the benefits...

Cost: $15

Where:
Moth & Moon Studio
173 South River Rd
Suite #4
Bedford, NH  03110
View map »


Sponsor: Jeffrey Charles Warren
Contact Name: Jeffrey Charles Warren
Website »

More information

Show More...
Show Less...

Show More...
Show Less...

April 1–May 27 With Yasemin Isler, MA and Juan José Miret, Ph.D. Why take Mindfulness-Based Stress Reduction (MBSR)? To better manage your stress and enhance...

Cost: $600–$650

Where:
Online
, MA


Sponsor: Center for Mindfulness and Compassion
Telephone: 617-591-6132
Website »

More information

Enrollment begins April 1 with special early-bird pricing for a limited time only!  Classes are October 2020 through May 2021 Faust Family Constellations presents The Constellation...

Where:
750 Pleasant St
Belmont, MA  02478
View map »


Contact Name: Jamy and Peter Faust
Website »

More information

12 month program starts April 1 Whether you're local or not, this could be a great choice for you, to join a community of like minded people and build out your knowledge, command, and...

Where:
Online
, MA


Sponsor: Crystal Concentrics
Contact Name: Kyle Russell
Website »

More information

30-DAY VIRTUAL TRAINING A Journey to Release Core Patterns and Open to Your Soul’s Purpose Is it possible that this forced time in isolation might be a perfect gift from the universe to...

Cost: Early Bird Discount $297

Where:
Online
, MA


Sponsor: Rhys Thomas Institute
Website »

More information

Show More...
Show Less...

Shocked and upset about the COVID-19 pandemic? Get Relief… Are you experiencing intense anxiety, fear, stress and negative thoughts you can't seem to control about: Losing...

Cost: Free

Where:
Online
, MA


Sponsor: Healing From the Body Level Up
Telephone: 781-444-6940
Contact Name: Judith A. Swack Ph.D.
Website »

More information

In these unprecedented times of uncertainty and fear all around, what foundation and practices can I rely on, to keep me calm, creative, peaceful, courageous? Join this session for a beginners...

Cost: Free

Where:
Online
, MA


Sponsor: Brahma Kumaris Learning Center for Peace
Telephone: (617) 926-1230
Website »

More information

Show More...
Show Less...

Show More...
Show Less...

Join a like-minded community working toward personal awakening in relation to family, ancestry and Soul agreements. Through the processes of family constellations, energy medicine and evolutionary...

Cost: $175

Where:
750 Pleasant St
Belmont, MA  02478
View map »


Contact Name: Jamy and Peter Faust
Website »

More information

Maintaining your inner stability is more important than ever during these challenging times. Learn techniques and meditation practices that will help keep your mind stable and peaceful. ...

Cost: Free

Where:
Online
, MA


Sponsor: Brahma Kumaris Learning Center for Peace
Telephone: (617) 926-1230
Website »

More information

April 4–5 Wake up to your cosmic consciousness and discoveryour duties to the stars, to the light, and to beloved Mother Earth. Joan Ruggiero shows you how to merge with your higher self,...

Where:
Circles of Wisdom
386 Merrimack Street, #1A
Methuen, MA  01844
View map »


Sponsor: Circles of Wisdom
Telephone: 978-474-8010
Contact Name: Cathy Kneeland
Website »

More information

Begins April 4 For Mental Health Professionals and Yoga Teachers, Students Yoga-Cognitive Behavioral Therapy (Y-CBT) is a new research based psychological paradigm that combines the...

Cost: See website

Where:
Available Remotely
, MA


Sponsor: Yoga At The Ashram
Telephone: 508-376-4525
Website »

More information

Show More...
Show Less...
Edit ModuleShow Tags
Edit Module Edit ModuleShow Tags